NEW YORK, NY — As the world enters the second week of October, a month traditionally dominated by pink ribbons and messages of early detection, a global movement is preparing to shift the spotlight toward a more sobering reality. On October 13, 2026, National Metastatic Breast Cancer Awareness Day, the #LightUpMBC campaign will see more than 325 iconic landmarks across 50 U.S. states and 20 countries illuminate in a triad of teal, green, and pink. This synchronized display of light aims to raise awareness for metastatic breast cancer (MBC)—the only stage of breast cancer that remains incurable.
Organized by METAvivor Research and Support, the campaign seeks to bridge the gap between general breast cancer awareness and the specific, life-critical needs of those living with Stage 4 disease. The evening will culminate in #LightUpMBC Live, a global broadcast featuring patient advocates, scientific experts, and world-class performers, all dedicated to a singular mission: transforming a terminal diagnosis into a manageable, chronic condition through dedicated research funding.
Main Facts: A Global Spectrum of Awareness
The #LightUpMBC campaign is not merely a visual spectacle; it is a calculated effort to reclaim the narrative of Breast Cancer Awareness Month for the nearly 200,000 Americans currently living with metastatic disease. While the color pink has long symbolized the fight against breast cancer, the #LightUpMBC campaign utilizes a specific color palette to represent the unique journey of the metastatic community:
- Teal: Symbolizing healing, spirituality, and the transition from life to the unknown.
- Green: Representing the hope of renewal, the triumph of spring over winter, and the growth of new research.
- Pink: Acknowledging the breast cancer origin of the disease.
The scale of the 2026 initiative is unprecedented. From the One World Trade Center in New York City and the Willis Tower in Chicago to the Mactan-Cebu Airport in the Philippines and the Ness Bridge in Scotland, the illumination serves as a global "roll call" for those lost to the disease and those currently fighting it.
"The reality of metastatic breast cancer is often lost in the broader conversation of ‘survivorship’ and ‘beating’ the disease," says Tami Eagle Bowling, #LightUpMBC Campaign Director and an 11-year survivor of MBC. "On October 13, we make the invisible visible. We light up the world to demand that the scientific community and the public recognize that Stage 4 needs more than awareness—it needs a cure."
Chronology: From a Single Bridge to a Global Movement
The history of #LightUpMBC is a testament to the power of grassroots advocacy and the enduring legacy of those who have passed.
2013–2016: The Catalyst of Diagnosis
The seeds of the movement were sown in 2013 when Dr. Kelly Shanahan, a physician and later METAvivor Board President, was diagnosed with metastatic breast cancer. Her diagnosis highlighted a glaring disparity in the oncology world: while billions were being funneled into early detection and prevention, only a fraction of breast cancer research funding was directed toward the metastatic stage—the stage that actually kills.
2017: The First Light
The campaign officially found its visual identity in 2017 through the efforts of Laura Inahara and her best friend, Jessica Moore. Jessica, who was diagnosed with MBC at age 32, had a simple dream: to see one local landmark lit in MBC colors to honor her struggle. That year, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to "Light Up" for MBC.
2018–2025: Exponential Growth
Following Jessica Moore’s death at age 36, Inahara turned her grief into a global initiative. What began as a single bridge in New Hampshire quickly spread to dozens of cities, then hundreds. By 2020, the campaign introduced #LightUpMBC Live, a virtual broadcast necessitated by the pandemic that ultimately allowed the movement to reach a global audience. Over the years, the campaign has raised more than $2.7 million specifically for Stage 4 research.
2026: The Largest Display in History
The October 13, 2026, event marks the largest iteration to date. With over 195 cities participating, the movement has evolved from a local tribute into a coordinated international diplomatic and health effort.
Supporting Data: The Statistical Urgency of Stage 4 Research
The necessity of the #LightUpMBC campaign is underscored by the stark epidemiological data surrounding breast cancer in the United States.
Mortality and Incidence
According to data from the National Cancer Institute’s SEER program, an estimated 42,670 people in the U.S. are expected to die from breast cancer in 2026. This equates to approximately 117 deaths every single day. Virtually all of these deaths are the result of metastatic disease.
The Nature of Metastasis
Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the circulatory or lymphatic system to other parts of the body. The most frequent sites of metastasis include:
- Bones: Often the first site of spread, causing pain and fractures.
- Liver: Impacting the body’s ability to filter toxins.
- Lungs: Leading to respiratory distress.
- Brain: Presenting significant neurological challenges.
Crucially, MBC remains breast cancer regardless of where it is found. A patient with breast cancer that has spread to the lungs does not have lung cancer; they have metastatic breast cancer, and they require treatments designed for breast cells.
The Funding Disparity
Historically, only 7% to 10% of all breast cancer research funding has been dedicated to metastatic disease. The remaining 90% is focused on prevention, early detection, and the treatment of early-stage (Stages 0–3) cancer. While these efforts have significantly increased the five-year survival rate for early-stage patients, they have done little to change the terminal nature of a Stage 4 diagnosis. METAvivor remains the only U.S. organization that dedicated 100% of its net proceeds exclusively to Stage 4 research.
Official Responses: Voices from the Front Lines
The leadership of METAvivor and the organizers of #LightUpMBC emphasize that while the lights are a symbol of hope, the ultimate goal is scientific progress.
Dr. Kelly Shanahan, METAvivor Board President:
"When I was diagnosed in 2013, I certainly didn’t think I’d still be here 13 years later. My survival is a direct result of the research that was funded a decade ago. But we are losing too many people while waiting for the next breakthrough. #LightUpMBC is our biggest contributor to this research. It is a way to bring us together as a community and to fund the scientists who are working to save our lives."
Laura Inahara, Founder of #LightUpMBC:
"Jessica Moore’s legacy is now shining in 20 countries. She wanted to illuminate one landmark; today, we are illuminating the world. This campaign teaches patients how to advocate for themselves and ensures that the families of those we’ve lost know their loved ones are not forgotten."
Tami Eagle Bowling, Campaign Director:
"Hosting #LightUpMBC Live is about more than just a show. It’s about sharing the scientific perspectives that give us hope and the patient stories that give us strength. We are showing the world that you can live with MBC, but we shouldn’t have to live in fear that our next treatment will fail."
Implications: Shifting the Paradigm of Cancer Care
The #LightUpMBC movement represents a broader shift in the oncology landscape—one that moves away from the "war" metaphor toward a model of chronic disease management.
From Terminal to Survivable
The primary objective of METAvivor’s research grants is to find ways to stop the progression of the disease or to make it responsive to long-term therapy. For many patients, the goal is no longer "cure" in the traditional sense (the total eradication of cancer), but rather "survivability"—living a high-quality life for decades while managing the cancer, much like one would manage diabetes or HIV.
The Role of Patient-Led Research
One of the most significant implications of METAvivor’s work is its peer-review process. Unlike many grant-making bodies, METAvivor includes patient advocates in the review of scientific proposals. This ensures that the research being funded is not just scientifically sound but also "patient-centric," focusing on treatments that preserve quality of life and address the symptoms that matter most to those living with the disease.
Global Advocacy and Awareness
The international reach of the 2026 campaign suggests a growing global recognition of the MBC crisis. By lighting landmarks in the Philippines, Scotland, and Canada, the campaign is fostering an international network of researchers and advocates. This global pressure is essential for encouraging pharmaceutical companies and governmental health agencies to prioritize Stage 4 clinical trials.
The Impact of "Pinktober" Fatigue
The #LightUpMBC campaign also serves as a necessary critique of "Pinkwashing." Many patients in the metastatic community report feeling isolated during October, as the focus on "survivorship" and "early detection" can feel like a dismissal of those for whom early detection did not work or was not an option. By designating October 13 as a day for the metastatic community, the movement provides a space for a more nuanced, honest conversation about the realities of cancer.
How to Participate in #LightUpMBC 2026
The public is encouraged to engage with the campaign through several channels:
- Photography: Citizens are invited to photograph participating landmarks on the night of October 13 and share them on social media using the hashtags #LightUpMBC and #METAvivor.
- The Live Stream: #LightUpMBC Live will air at 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling and Broadway star Kara Lindsay, the program features performances by Tony Award winners like Victoria Clark and scientific insights from leading oncologists.
- Donations: 100% of the net proceeds from the campaign go directly to MBC research grants.
As the lights turn teal, green, and pink this October 13, the message is clear: awareness is the first step, but research is the only way forward. For the 117 people who will lose their lives to breast cancer today, and the 117 who will lose theirs tomorrow, the lights offer a beacon of hope that one day, Stage 4 will no longer be the end of the story.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer. It is the only organization of its kind in the U.S. that funds MBC research through a transparent, peer-reviewed process.
Press Contact:
Tami Eagle Bowling
[email protected]
www.lightupmbc.org
About the Author
